InvestorsHub Logo
Followers 0
Posts 178
Boards Moderated 0
Alias Born 12/04/2013

Re: Fred Kadiddlehopper post# 5241

Saturday, 04/15/2017 1:18:16 PM

Saturday, April 15, 2017 1:18:16 PM

Post# of 8489
Well it was clear why Baxter did the deal with HALO on Hylenex and it wasn't to sell it! Product suppression is the phrase that springs to mind. I have a horrible feeling that they have done the same to HALO on HyQ too. Roche haven't exactly been rushing to get SQ Mabthera and Herceptin approved in the US either have they? Sometimes corporate profits come before patients. These actions have resulted in the original plan of paying for in-house drug developments out of the royalty streams from partners look seriously flawed. HALO is burning money like confetti and there will have to be many more fundraisings before PEG ever comes to market in the 2020's - that's if it's ever approved of course.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News